© 2026 Sinochem Nanjing Corporation,
All Right Reserved
(R)-9-(2-Hydroxypropyl)Adenine belongs to the family of purine derivatives, recognized in the labs and manufacturing plants for its important role in pharmaceutical synthesis and biomedical research. It originates from modifications on the adenine backbone where a hydroxypropyl moiety attaches at the 9-position of the molecule. This small structural change creates new physical and chemical characteristics that set it apart from simple adenine or its other analogs. The scientific community recognizes its molecular formula as C8H11N5O, combining elements in a way that supports both reactivity and stability. Originally, researchers needed a substance that could bridge the gap between nucleic acid analogs and active pharmaceutical ingredients, and this compound fit that need thanks to its mix of solubility, chemical reliability, and versatility as a raw material.
The chemical structure of (R)-9-(2-Hydroxypropyl)Adenine gives it a unique identity—purine base fused with a chiral hydroxypropyl group. The presence of a chiral center marks the difference between (R)- and (S)- isomers, and in biomedical applications, this enantiomeric purity directly affects efficacy and metabolism. This chiral configuration also speaks to why quality control matters so much in drug development; an incorrect ratio of enantiomers changes the function or may introduce risk. Its melting point generally ranges from 205 to 209°C, and it tends to exist as a white or near-white crystalline solid. In bulk, one finds it as powder, flakes, or occasionally as larger crystals, depending on the processing method.
Daily handling of (R)-9-(2-Hydroxypropyl)Adenine shows flexible options in physical form. In commercial supply chains, it’s common to receive the compound as a dry powder or as fine crystalline flakes. The distinction between powder and flakes often connects to end-use: researchers prefer finer powders for weighing and mixing, while bulk manufacturers might opt for larger flakes or pearls to improve stability over long-term storage. There’s a key reason why material in the form of pearls or larger crystals holds value—the lower surface area slows reaction with air or moisture, maintaining product quality longer on the shelf. Density can vary, but data usually points to values around 1.5 to 1.6 g/cm³ in the solid phase.
True to the needs of chemists, this material dissolves in water to some extent, though far less than simple salts or sugars. Solubility in organic solvents like methanol or DMSO is generally better. In my own work with nucleoside analogs, the solubility profile often sets the pace for reaction efficiency and yield. When preparing a standard 1-liter solution for assay development, using purified water with gentle heat eases dissolution, though stirring for several hours is sometimes necessary. The importance of that solubility goes beyond simple mixing: in synthesis of antiviral drugs, for example, the ability to blend homogeneously can decide whether a batch meets specification or not.
There’s always risk in handling any new chemical, and (R)-9-(2-Hydroxypropyl)Adenine is no exception. It appears as a stable, non-volatile solid, but accidental inhalation or skin contact can lead to moderate irritation in sensitive individuals. According to the material safety data, ingesting significant amounts can cause harmful effects, so routine use of gloves and eye protection is more than just a workplace regulation—it’s a matter of daily practice for anyone in the lab. Even though the chemical does not rank as highly hazardous under GHS regulations, responsible waste disposal and containment during use remain critical. Incompatibility with strong oxidizing agents stands as a reminder to maintain clean benches and avoid accidental mixing with the wrong type of reagent.
Manufacturers place this compound high on the list for nucleoside synthesis, anti-cancer research, and drug formulation. Its HS Code, often categorized as 293399 or similar for heterocyclic compounds, assists in the regulation and transport across borders—a step where compliance connects to safety, economic stability, and access to research materials worldwide. My collaboration with supply groups has underscored how paperwork, handling records, and batch provenance impact the reliability of both research results and commercial outputs. A consistent, high-purity raw material means fewer recalls, better patient outcomes, and reduced environmental risk.
What stands out about (R)-9-(2-Hydroxypropyl)Adenine isn’t just the technical specs printed on a data sheet, but the real-world role in furthering science. Chemists value the chiral specificity, manufacturers rely on reliable bulk supply, and regulatory teams look for clear, well-documented hazard assessments. The current challenge lies in improving both accessibility and safety—by investing in greener synthesis routes, automating quality checks, and being transparent with end users about risks and safe use. Committing to quality at every step—raw material, process, packaging—keeps both people and the planet healthier as more innovate with compounds like this.
